Literature DB >> 18788914

Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa.

Mélanie Caron1, Maria Makuwa, Sandrine Souquière, Diane Descamps, Françoise Brun-Vézinet, Mirdad Kazanji.   

Abstract

Miners in sub-Saharan African are known to have an extremely high prevalence of HIV-1 infection. We therefore evaluated the prevalence of HIV-1 infection among manganese miners in Gabon, central Africa and examined the diversity of HIV-1 strains by characterizing the polymorphism of the pol gene in order to observe drug resistance-associated mutations. In 857 samples tested, the HIV-1 prevalence was 2.9%. By pol sequence analysis, we showed that all the HIV-1 strains belonged to group M, with a majority of CRF02_AG (57%) followed by subtype A (9%) and CRF01_AE or subtype B (4%). The remaining HIV-1 strains demonstrated discordant genomic results and exhibited a mosaic pol genome (30%). Most of the mutations detected in pol coding regions corresponded to the subtype polymorphism, with no specific antiretroviral drug resistance. To avoid the rapid emergence of resistant viruses in this part of central Africa, continuous surveillance of the circulation of drug-resistant viruses must be maintained to guide treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18788914     DOI: 10.1089/aid.2008.0097

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

Review 1.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

2.  Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.

Authors:  Nuno R Faria; Marc A Suchard; Ana Abecasis; João D Sousa; Nicaise Ndembi; Idalina Bonfim; Ricardo J Camacho; Anne-Mieke Vandamme; Philippe Lemey
Journal:  Infect Genet Evol       Date:  2011-05-04       Impact factor: 3.342

3.  HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report.

Authors:  I I Amarakoon; A Ramkissoon; R Pierre; L M Eyzaguirre; J K Carr; W A Blattner; M E Roye
Journal:  West Indian Med J       Date:  2014-08-21       Impact factor: 0.171

4.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

5.  Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa.

Authors:  Mélanie Caron; Sonia Etenna Lekana-Douki; Maria Makuwa; Guy-Patrick Obiang-Ndong; Olivia Biba; Dieudonné Nkoghé; Mirdad Kazanji
Journal:  BMC Infect Dis       Date:  2012-03-20       Impact factor: 3.090

6.  Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.

Authors:  Florian Liégeois; Caroline Vella; Sabrina Eymard-Duvernay; Jeanne Sica; Laurent Makosso; Augustin Mouinga-Ondémé; Arnaud Delis Mongo; Vanina Boué; Christelle Butel; Martine Peeters; Jean-Paul Gonzalez; Eric Delaporte; François Rouet
Journal:  J Int AIDS Soc       Date:  2012-11-28       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.